Turn Therapeutics Inc.
TTRX
Positions held
Your positionsTTRX isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $345.89M | Enterprise value | $335.12M | Trailing P/E | — | Forward P/E | -75.93 |
| PEG | — | Price / book | 495.22 | Beta | — | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -6.9% | ROA | -50.3% | Debt / equity | 8.91 |
| Current ratio | 1.19 | Free cash flow | $4.17M | Analyst recommendation | strong_buy | Mean target | $25.00 |
| 52w high | $16.45 | 52w low | $2.57 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$5.8M | -$1.0M | $0.3M | -$1.9M | -$1.2M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$1.6M | -$1.2M | -$2.2M | -$1.9M | -$1.4M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — |
| Net income | -$3.2M | -$1.8M | -$2.3M |
| Gross margin | — | — | — |
| Gross profit | — | — | — |
| Operating income | -$5.9M | -$1.8M | -$2.3M |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-10 · Turn Therapeutics to Present at Stifel 2026 Virtual Immunology and Inflammation Forum
2026-09-09 · Turn Therapeutics Appoints Former CDC Director Robert R. Redfield, M.D., as Chief Scientific Officer
2026-09-08 · NovaBridge Appoints Martin Dewhurst to Board of Directors as an Independent Director
2026-08-12 · Turn Therapeutics Provides Corporate Updates and Reports Second Quarter 2026 Financial Results
2026-07-28 · Turn Therapeutics to Ring the Nasdaq Closing Bell on Monday, August 10, 2026
2026-07-11 · Turn Therapeutics Refines GX-03 Eczema Trial After Interim Data, Eyes 2026 Readout
Price (daily)
Full chart · RSI · MACD · patterns